pelareorep – Patient Worthy

Source: Pixabay.com

GOBLET Clinical Trial to Evaluate Pelareorep & Atezolizumab for Pancreatic, Anal Cancers

Post author:Jessica Lynn
Post published:January 6, 2021
Post category:Anal Cancer Pancreatic Cancer

According to OncLive, Oncolytics Biotech and Roche are pairing up to run a new German Phase ½ clinical trial. The GOBLET trial will evaluate pelareorep in conjunction with atezolizumab (Tecentriq)…

CLICK HERE TO SHARE YOUR STORY!

We believe rare disease patients are people, not a diagnosis. Through education, awareness and some humor, we help patients, caregivers and support persons by providing relevant and often inspirational news and stories.

Our goals are to share stories, cultivate strong community, provide the latest medical findings, connect people and pioneer production of patient worthy information. Help us attain these goals by telling us a little bit about yourself!

GOBLET Clinical Trial to Evaluate Pelareorep & Atezolizumab for Pancreatic, Anal Cancers

Metastatic Breast Cancer: Navigating Grief

Rethinking What It Means to Live With Acromegaly

The Let’s Chat CAR T One-on-One Mentor Program: Speaking with Someone Who Understands What You Are Going Through

Let’s Work Together!

Keep Up to Date

Learn More